Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

June 27, 2024

Study Completion Date

June 27, 2024

Conditions
Peripheral Nerve Injuries
Interventions
COMBINATION_PRODUCT

NTX-001

One time use surgical product, 3 solutions applied topically, in sequence, to the peripheral nerve repair site, in conjunction with standard suture neurorrhaphy. An isolation chamber medical device (device) is utilized to focus the application of PEG (Solution #2) on the coapted nerve for the required amount of exposure time.

Trial Locations (10)

21218

Curtis National Hand Center, Baltimore

21224

Johns Hopkins Bayview Medical Center, Baltimore

23398

Virginia Commonwealth University, Richmond

32607

UF Health - University of FL - Gainesville, Gainesville

32806

Orlando Health, Orlando

43202

The Ohio State University Wexner Medical Center Hand and Upper Extremity Center, Columbus

46260

Indiana Hand to Shoulder Center, Indianapolis

60637

University of Chicago, Chicago

63110

Washington University, St Louis

98107

Harborview Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Neuraptive Therapeutics Inc.

INDUSTRY